News About: Pharm. Industry
Debate flares up over domestic generic drug price
The Korean Research based Pharmaceutical Industry Association (KRPIA) and the Korea Pharmaceutical Manufacturers Association (KPMA) have conflicting views on the prices of local generic drugs.
The KRPIA said in its...
US FDA OKs Korean neutropenia treatment drug
Hanmi Pharm said it has received approval from the U.S. Food and Drug Administration to conduct Phase 1 clinical trial of LAPS-GCSF (HM10460A, a drug for the treatment of neutropenia, following an approval on novel er...
Oral premature ejaculation to go on sale in Korea
Jassen Korea says its oral premature ejaculation medicine “Priligy” (dapoxetine) will be available in Korea from October 20, the first launching in Asia.
Premature ejaculation is a distressing sexual dysfunction th...
Questions raised over domestically produced vaccine
Controversy on the safety of locally available vaccine will heat up as a total of thee elderly people died on October 5, 6 and 7 after being shot with seasonal vaccines produced by Green Cross Corporation.
Health a...
Samyang Genex to gear up export for European market
Samyang Genex said it has recently signed an agreement with an European multinational firm to supply its anticancer drug “Genexol“ (paclitaxel), paving a way to make inroad into an European market.
This agreement w...
Viromed, Eureka to conduct joint research over antibody cancer drug
ViroMed Co., a local biopharmaceutical company, says it has signed a memorandum of understanding with the US based Eureka Therapeutics Inc. to accelerate the development of antibody cancer drugs, such as Swiss Drug Gi...
KPMA to look into drug makers
The Korea Pharmaceutical Manufacturers Association (KPMA), a local pharmaceutical business lobby group, has embarked on looking into eight drug makers’ undue business practices such as rebate-offering, according to a ...
Drug agency grilled over Tamiflu shelf-life extension
An opposition party lawmaker raised suspicions on the nation’s drug agency decision to extend the shelf life of the flu drug Tamiflu by two years, , during the parliamentary audit to the Korea Food and Drug Administra...
Oscotec discovers bone growth compound
Oscotec Inc., a bone specialized biotech company based in Korea, says it has discovered a promising drug candidate to facilitate the bone growth under a two-year joint research with Harvard Medical School’s Institute ...
Ildong witnesses impressive multivitamin sales
Ildong Pharm said its multivitamin Aronami-C Plus garnered 11.5 billion won in sales in the January-September period, thanks much to big popularity in all age groups.
The company forecast its sales will exceed 14.5...
